ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,936Medicare Part D Prescriptions Filled, Including Refills

Rank: 292 out of 1677

$654K Total Retail Price of All Prescriptions

Rank: 210 out of 1677

368 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 368 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 368 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 8,135 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 484 334 1 5
AMLODIPINE BESYLATE 415 380 2 2
LISINOPRIL 379 331 3 3
OMEPRAZOLE 373 295 4 6
ATORVASTATIN CALCIUM 335 288 5 13
HYDROCODONE-ACETAMINOPHEN 304 194 S3 6 4
SIMVASTATIN 279 263 7 1
FUROSEMIDE 211 175 8 8
METOPROLOL TARTRATE 209 166 9 12
LOSARTAN POTASSIUM 181 164 10 25
CARVEDILOL 153 126 11 20
SYNTHROID 153 134 11 55
CLONIDINE HCL 152 150 13 36
HYDROCHLOROTHIAZIDE 150 128 14 9
METFORMIN HCL 143 107 15 7
PRAVASTATIN SODIUM 141 107 16 10
ZOLPIDEM TARTRATE 140 100 17 15
TRAMADOL HCL 132 84 18 16
RANITIDINE HCL 131 93 19 18
METOPROLOL SUCCINATE 126 121 20 23
FENOFIBRATE 124 89 21 48
CYMBALTA 123 82 22 58
GABAPENTIN 118 84 23 11
SERTRALINE HCL 112 60 24 26
NAMENDA 101 101 25 39
TRAZODONE HCL 98 83 26 37
DONEPEZIL HCL 97 93 27 30
ALLOPURINOL 97 84 27 31
NEXIUM 95 62 29 19
GEMFIBROZIL 91 48 30 113
FLUOXETINE HCL 88 71 31 49
CITALOPRAM HBR 84 62 32 22
TRICOR 83 72 33 100
ESTRADIOL 83 47 R 33 129
POTASSIUM CHLORIDE 80 62 35 14
AMITRIPTYLINE HCL 78 39 R 36 63
DIOVAN 77 72 37 45
LYRICA 77 0 37 81
PANTOPRAZOLE SODIUM 76 62 39 46
CRESTOR 75 56 40 28
BENAZEPRIL HCL 73 71 41 53
PAROXETINE HCL 70 43 42 67
FLUTICASONE PROPIONATE 68 46 43 29
TRIAMTERENE-HCTZ 62 34 44 61
EVISTA 62 51 44 162
ATENOLOL 61 57 46 21
MELOXICAM 61 45 46 27
LIPITOR 61 28 46 101
ZETIA 60 51 49 75
GLIPIZIDE ER 59 53 50 78
ALENDRONATE SODIUM 55 32 51 43
CIPROFLOXACIN HCL 52 48 52 57
SPIRIVA 51 23 53 74
PROAIR HFA 51 17 53 50
LOSARTAN-HYDROCHLOROTHIAZIDE 51 46 53 42
CYCLOBENZAPRINE HCL 51 11 R 53 52
LANSOPRAZOLE 50 23 57 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.